FT.CE.18 ear spray for ear canal hygiene, protection and prevention The registration of the FT.CE.18 medical device with the Executive Department of Medical Devices Evaluation of the Medical Devices Sector of the Kingdom of Saudi Arabia marks a significant milestone in the international expansion of medical devices designed for ear hygiene and protection. This approval…
Discover our innovative technologies for the future of formulation We are excited to announce that we will once again be present at CPHI Worldwide in Frankfurt, the most important global event for the pharmaceutical and nutraceutical industry. We look forward to seeing you from October 28 to 30 2025, Hall 5 Booth 50A84, to present…
Lattawin Ovules: the effective medical device against irritation and intimate burning Dryness, burning, itching, irritation, and discomfort during intercourse are common but often overlooked symptoms that affect many women at all stages of life. Whether due to hormonal changes, menopause, stress, antibiotic use, or imbalances in the vaginal microbiota, these disturbances can compromise quality of…
Introduction to Alzheimer’s disease and current therapies Alzheimer’s disease (AD) is the most common form of neurodegenerative dementia and represents a growing health challenge. In 2022, about 55 million people were affected, and it is estimated that the number could reach 139 million by 2050. Current treatments are only symptomatic and show limited efficacy: they…
Acne: problems and the search for new solutions Acne vulgaris, a dermatological disorder that mainly affects adolescents and young adults, goes far beyond simple aesthetic problems. Its physical manifestations, such as comedones, papules, and pustules, can leave permanent scars, while the psychological impact, which includes anxiety and depression, compromises the quality of life. While numerous…
Clinically Proven Effectiveness of Our Hyaluronic Acid-Based Vaginal Medical Device for Women’s Intimate Health Gruppo FarmaImpresa is proud to share the results of its clinical study, conducted on the medical device Revaginal Ovules. The study evaluated the safety and effectiveness of our vaginal ovules in promoting vaginal and uterine tissue regeneration, offering an innovative and…
Towards Personalized Nutraceuticals Based on Microbiota and Metabolic Profile Prediabetes is an increasingly common condition and represents an important risk factor for the progression to type 2 diabetes. In addition to lifestyle interventions, there is growing interest in nutraceutical strategies aimed at improving glycemic control. A recent study published in Nature Microbiology analyzed the effectiveness…
A Medical Device Based on Sodium Hyaluronate to Create the Ideal Environment for Natural Conception The Key Role of Sperm Motility in Conception Sperm motility is the ability of spermatozoa to move autonomously through the female reproductive tract to reach and fertilize the ovum. Factors such as vaginal pH, osmolality, and the presence of nutrients…
New evidence links flavan-3-ols and mortality in the MetS population Clinical context: polyphenols and risk in metabolic syndrome Metabolic syndrome (MetS)—a combination of abdominal obesity, hypertension, dyslipidemia, and insulin resistance—affects a significant proportion of the adult population and is associated with increased mortality. In this scenario, dietary bioactive compounds, particularly flavan-3-ols (catechins found in tea,…
Gruppo FarmaImpresa Registers Its Production Plant in Libya: A New Milestone for International Expansion Gruppo FarmaImpresa proudly announces the registration of its production plant in Libya, a strategic step that solidifies the company’s presence in the MENA (Middle East and North Africa) region. This recognition guarantees quality, safety, and excellence for our local and international…